CSCIED

期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Journal of Clinical Research. 2022; 6: (7) ; 29-38 ; DOI: 10.12208/j.ijcr.20220300.

The Efficacy and Safety of Azitromycin Combined with Purdue Blue in the Treatment of Pediatric Mycoplasma Pneumonia: A Meta-analysis
阿奇霉素联合蒲地蓝治疗小儿支原体肺炎的临床疗效及安全性Meta分析

作者: 栗亮, 韩新 *, 李虎

枣庄职业学院 山东枣庄

*通讯作者: 韩新,单位:枣庄职业学院 山东枣庄;

发布时间: 2022-09-07 总浏览量: 467

摘要

目的 评价阿奇霉素联合蒲地蓝治疗小儿支原体肺炎的临床疗效及安全性。方法 计算机检索Cochrane Central Register of Controlled Trials、Joanna Briggs Institute Library、Science、Web of Science、MEDLINE、Pub Med、中国生物医学文献库(CBM)、维普(VIP)、中国知网(CNKI)、万方数据资源系统中关于阿奇霉素联合蒲地蓝治疗小儿支原体肺炎效果的随机对照试验,同时采用滚雪球方法筛选纳入文献的参考文献。由2名研究者进行纳入文献质量评价并提取研究相关的信息,采用软件RevMan5.3版进行Meta分析。结果 纳入8项随机对照试验(RCT),共883例患者。Meta分析结果表明,阿奇霉素联合蒲地蓝治疗组的临床疗效(P<0.00001),发热消失时间(P<0.00001),血清炎性因子:白介素-6(IL-6)(P<0.00001)、白介素-8(IL-8)(P<0.00001)、C反应蛋白(CRP)(P=0.01)、肿瘤坏死因子(TNF-α)(P<0.00001)、免疫干扰素(INF-γ)(P<0.00001),T淋巴细胞亚群CD4+T细胞/CD8+T细胞(P<0.00001)均显著优于阿奇霉素治疗组;两者在不良反应的发生率(P=0.86),T淋巴细胞亚群:CD3+T细胞(P=0.21)、CD4+T细胞(P=0.81)、CD8+T细胞(P=0.98),血清炎性因子:降钙素原(PCT)(P=0.34)方面比较,差异无统计学意义。结论 采用蒲地蓝辅助阿奇霉素治疗小儿支原体肺炎,可以显著增加临床疗效、缩短发热消失的时间,改善患儿外周血中T淋巴细胞亚群、降低血清炎性因子的浓度,提高机体免疫水平,促进炎症快速吸收。

关键词: 小儿支原体肺炎;阿奇霉素;蒲地蓝;Meta 分析

Abstract

Objective: To evaluate the efficacy and safety of azitromycin combined with Purdue blue in the treatment of pediatric mycoplasma pneumonia.
Methods The Cochrane Central Register of Controlled Trials, Joanna Briggs Institute Library, Web of Science, Science, MEDLINE, PubMed, Web of Knowledge CNKI, Wanfang Data and CBM were searched to collect randomized controlled trials (RCTs) on using azitromycin combined with Purdue blue in the treatment of pediatric mycoplasma pneumonia. The quality of the studies was critically appraised and data were extracted by 2 reviewers independently, and meta-analysis was conducted.
Results A total of 8 RCTs were chosen, involving 883 patients. The results of meta-analysis demonstrated that when used for children with mycoplasma pneumonia, azitromycin combined with Purdue blue could increase efficacy,CD4+ T cell/CD8+ T cell.Antipyretic time, C-reactive protein, Interleukin-6, Interleukin-8 and interferon-γ in azitromycin combined with Purdue blue group were significantly lower than those in azitromycin group. There was no significant difference between the two groups in the aspects of procalcitonin, CD3+ T cell, CD4+ T cell, CD8+ T cell, CD4+ T cell/CD8+ T cell and adverse effects.
Conclusion   Azitromycin combined with Purdue blue can effectively increase efficacy, shorten the time of Antipyretic, improve the T lymphocyte subsets, reduce the concentration of serum inflammatory factors, improve the immune level of the body, and promote the rapid absorption of inflammation in children with mycoplasma pneumonia.

Key words: Pediatric Mycoplasma Pneumonia; Azitromycin; Purdue Blue; Meta-Analysis

参考文献 References

[1] 任明星,薛国昌,沈琳娜等. 甲泼尼龙联合阿奇霉素治疗小儿难治性支原体肺炎的疗效与安全性分析[J]. 中国全科医学,2015,18(05):588-591 

[2] Eun-Kyung Kim, You-Sook Youn, Jung-Woo Rhimet al. Epidemiological comparison of three Mycoplasma pneumoniae pneumonia epidemics in a single hospital over 10 years[J]. Korean J Pediatr, 2015, 58(5): 172-177 

[3] 官小宁,王道聪. 蒲地蓝与阿奇霉素联用对小儿支原体肺炎的影响[J]. 医学美学美容,2020,29:112 

[4] 朱树丽,王媛媛,张晓春. 中医及中西医结合治疗小儿支原体肺炎进展[J]. 辽宁中医药大学学报,2012,14(6):250-252 

[5] 江载芳,吴瑞萍,胡亚美. 实用儿科学[M]. 北京: 人民卫生出版社,1997:1171-1172 

[6] 胡亚美,江载芳. 诸福堂实用儿科学[M]. 北京: 人民卫生出版社,2002:1204-1205 

[7] 中华中医药学会.中医儿科常见病诊疗指南[M].北京:中国中医药出版社,2012:28. 

[8] 韩新,曹艳佩,杨晓莉等. 枸橼酸盐和肝素钠用于成人血液透析导管封管有效性的Meta分析[J]. 护理学杂志,2015,21(30):88-92 

[9] 栗亮,韩新,李虎等. 阿仑膦酸钠联合阿托伐他汀治疗糖尿病合并骨质疏松的临床疗效及安全性Meta分析[J]. 中国骨质疏松杂志,2020,12(26):1836-1842 

[10] 许丽春,胡雁,张锦辉等. 生理盐水和肝素钠盐水用于成人外周静脉留置针封管有效性的Meta分析[J]. 护理学杂志,2014,29(19):82-86 

[11] 王燕萍,王晓玲. 蒲地蓝联合阿奇霉素治疗小儿支原体肺炎的临床有效性分析[J]. 山西医药杂志,2019,48:1711-1713 

[12] 陈云,胡立杰,王婷婷. 蒲地蓝口服液联合阿奇霉素治疗对支原体肺炎患儿血清炎性因子及免疫功能的影响[J]. 世界中医药,2018,13:2449-2452 

[13] 蒋银,刘荣,顾明. 蒲地蓝联合阿奇霉素治疗小儿支原体肺炎效果分析[J]. 医药前沿,2018,8(25):102-103 

[14] 陈占峰,万春辉. 蒲地兰联合阿奇霉素对小儿支原体肺炎患者T淋巴细胞亚群临床影响研究[J]. 河北医学,2016,22:1647-1649 

[15] 郭亚波. 蒲地蓝消炎口服液联合阿奇霉素治疗小儿支原体肺炎50例[J]. 中国中医药现代远程教育,2016,14:100-101 

[16] 郭亦男. 蒲地蓝联合阿奇霉素治疗小儿支原体肺炎的临床疗效及对细胞炎症因子的影响[J]. 中国处方药,2016,14:79, 80 

[17] 夏建新,陆钱峰,邵洁. 蒲地蓝联合阿奇霉素治疗小儿支原体肺炎的临床研究[J]. 中国高等医学教育,2015:137, 140 

[18] 楼洪刚,刘芳,翟所迪. 氨溴索雾化吸入治疗肺炎的系统评价[J]. 中国循证医学杂志,2006(06):421-429 

[19] 梁景林. 阿奇霉素序贯疗法治疗小儿支原体肺炎的分析[J]. 当代医学,2012,18(26):135-136

赵丹,候旭东,李涵. 大环内酯类抗生素联合麻甘颗粒、蒲地蓝治疗儿童肺炎支原体肺炎的效果对比及分子机制探讨[J].中国医学创新,2021,18(11):49-53. 

引用本文

栗亮, 韩新, 李虎, 阿奇霉素联合蒲地蓝治疗小儿支原体肺炎的临床疗效及安全性Meta分析[J]. 国际临床研究杂志, 2022; 6: (7) : 29-38.